Capital World Investors
CCXI

Capital World Investors’s ChemoCentryx, Inc. CCXI Stock Holding History

Capital World Investors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,489,848
Closed -$3.71M – 520
2016
Q1 		$3.71M Sell
1,489,848
-1,977,392
-57% -$7.2M ﹤0.01% 472
2015
Q4 		$28.1M Hold
3,467,240
– – 0.01% 399
2015
Q3 		$21M Hold
3,467,240
– – 0.01% 419
2015
Q2 		$28.5M Hold
3,467,240
– – 0.01% 411
2015
Q1 		$26.2M Hold
3,467,240
– – 0.01% 422
2014
Q4 		$23.7M Buy
3,467,240
+40,440
+1% +$214K 0.01% 432
2014
Q3 		$15.4M Hold
3,426,800
– – ﹤0.01% 450
2014
Q2 		$20M Hold
3,426,800
– – 0.01% 428
2014
Q1 		$22.7M Buy
3,426,800
+295,000
+9% +$2.05M 0.01% 414
2013
Q4 		$18.1M Hold
3,131,800
– – 0.01% 426
2013
Q3 		$17.4M Buy
3,131,800
+1,060,217
+51% +$11.5M 0.01% 416
2013
Q2 		$29.3M Buy
+2,071,583
New +$26.8M 0.01% 374

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Capital World Investors's CCXI Position: Q2 2016 in Review

Capital World Investors sold out of ChemoCentryx, Inc. (CCXI) in Q2 2016, closing a stake of 1,489,848 shares — an estimated $3.71M sold.

Capital World Investors first reported a position in CCXI in Q2 2013 and held it in 12 quarters. The position peaked at $29.3M in Q2 2013. 77 funds tracked by Wall St. Rank hold CCXI as of Q2 2016.

  • Capital World Investors reported no remaining ChemoCentryx, Inc. position as of Q2 2016 after selling out during the quarter.
  • Capital World Investors sold 1,489,848 ChemoCentryx, Inc. shares in Q2 2016, an estimated $3.71M.
  • Capital World Investors first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 12 quarters.
  • Capital World Investors's ChemoCentryx, Inc. position peaked at $29.3M in Q2 2013.
  • 77 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2016.

Based on Capital World Investors's 13F filing for Q2 2016, filed 15 Aug 2016.